Agenda

Number of rights: 69

Price of the Purchase Commitment by ACS: 1.866 gross euros per right

Agenda

June 17, 18, 19, 22 and 23, 2026: Dates for the purpose of calculating the PreCot.

June 24, 2026: Decisions to initiate the first execution of the bonus share capital increase setting the dates of the first execution of the capital increase and the simultaneous capital reduction, as well as the terms thereof, including the number of free allocation rights necessary to receive one share and the definitive price of the Purchase Commitment assumed by ACS. Publication of the main terms of the first execution of the capital increase by means of an informative document sent to the CNMV (and communication of other relevant information attaching such informative document). Waiver by ACS of the free allocation rights corresponding to the treasury shares held by ACS and of the new shares corresponding to the free allocation rights held by ACS at the end of the trading period for such rights as a consequence of the Purchase Commitment.

June 25, 2026: Publication of the BME PC.

June 26, 2026: Publication of the announcement of the first execution of the capital increase and the simultaneous capital reduction in the BORME. Last day on which ACS shares are traded with the right to participate in the first execution of the capital increase (last trading date).

June 29, 2026: Beginning of the trading period of the free allocation rights and of the period for requesting the cash remuneration (sale of rights to ACS) under the purchase commitment assumed by ACS. Date as from which ACS shares are traded without the right to participate in the first execution of the capital increase (ex-date).

June 30, 2026: Date of determination by Iberclear of the positions for the allocation of free allocation rights (record date).

July 1, 2026: Date of allocation of the free allocation rights.

July 6, 2026: End of the period for requesting cash remuneration (sale of free allocation rights to ACS) by virtue of the Purchase Commitment assumed by ACS.

July 13, 2026: End of the trading period for the free allocation rights. Acquisition by ACS of the free allocation rights from shareholders who have opted to receive cash under the Purchase Commitment assumed by ACS (DAGs Purchase and Sale Transaction Date).

July 14, 2026: Confirmation by ACS of the final number of free allocation rights held by ACS at the end of the trading period thereof and which it has previously waived. End of the First Execution of the capital increase.

July 15, 2026: Cash payment to shareholders who have requested cash remuneration under the purchase commitment assumed by ACS (DAGs purchase and sale settlement date).

July 15, 2026: Execution and filing with the Commercial Registry of the deed of the first execution of the capital increase and the simultaneous capital reduction.

July 17, 2026: Delivery of the deed of the first execution of the capital increase and the simultaneous capital reduction and the corresponding documentation to Iberclear, Bolsas and CNMV [1].

July 21, 2026: Authorization CNMV and Stock Exchanges. Registration of the new shares to be issued as a result of the first execution of the capital increase and cancellation of the shares to be redeemed as a result of the simultaneous capital reduction in Iberclear's accounting records.

July 22, 2026: Start of trading of the new shares on the Spanish Stock Exchanges [2].

[1] Subject to the registration deadlines of the Commercial Registry.
[2] Subject to the specific verification and admission agreements.